Work

Harnessing artificial intelligence and machine learning to accelerate structure-based drug discovery for tuberculosis

Year: 2025
Type: editorial
Abstract: 1. The structure-based drug design (SBDD) leverages the structural insights for rational development of small molecules with optimized affinity/selectivity [1,2]. For Mycobacterium tuberculosis (Mt...
Language: English
Open Access status: bronze
OpenAlex ID: W7117533965
Cites: 28
Cited by: 5
Related to: